Gilead Sciences Inc (NASDAQ:GILD)
| 70.67 Delayed Data As of 4:57pm ET |  -1.06 / -1.48%Today’s Change | 60.89 Today|||52-Week Range 85.97 | +8.76% Year-to-Date |
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 71.73 |
| Today’s open | 72.02 |
| Day’s range | 70.48 - 72.30 |
| Volume | 578,635 |
| Average volume (3 months) | 14,679,371 |
| Market cap | $87.2B |
Data as of 4:57pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +0.91% |
| Earnings growth (this year) | +5.20% |
| Earnings growth (next 5 years) | +0.66% |
| Revenue growth (last year) | +0.49% |
| P/E ratio | 18.1 |
| Price/Sales | 3.72 |
| Price/Book | 3.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -4.15 | -1.04% |
| BIIBBiogen | -1.91 | -0.69% |
| AMGNAmgen | -3.69 | -1.49% |
| MRNAModerna Inc | +0.54 | +0.69% |
Data as of 5:21pm ET, 08/04/2020
Financials
| Next reporting date | October 22, 2020 |
| EPS forecast (this quarter) | $1.99 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $5.4B |
| Net profit margin | 24.13% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
